Navigation Links
Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
Date:6/9/2009

Long-Term Data in Patients Receiving Every-Four-Week Subcutaneous SIMPONI Presented at 2009 EULAR Annual Congress

COPENHAGEN, June 9 /PRNewswire/ -- Findings from open-labeled, uncontrolled extensions of two randomized, placebo-controlled Phase 3 studies showed that subcutaneous (SC) injections of SIMPONI(TM) (golimumab) 50 mg or 100 mg every four weeks provided persistent improvements in the signs and symptoms in patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS). Investigators reported these new data from the long term treatment extensions of the GO-REVEAL and GO-RAISE trials at the 2009 European League Against Rheumatism (EULAR) Annual Congress.

In the Golimumab - A Randomized EValuation of Safety and Efficacy in Subjects with Psoriatic Arthritis Using a Human Anti-TNF MonocLonal Antibody (GO-REVEAL) study, patients with active PsA were randomized to placebo (n=113), SIMPONI 50 mg (n=146) or SIMPONI 100 mg (n=146). Of the 405 patients originally randomized in the Phase 3 study, a two-year observational analysis of 276 patients remaining in the study and evaluated at two years was performed. Sixty-four of 70 patients who received SIMPONI 50 mg and 95 of 130 patients who received SIMPONI 100 mg achieved ACR 20, respectively. Forty-three of 76 patients receiving SIMPONI 50 mg who switched to SIMPONI 100 mg in early escape also achieved ACR 20. At least 50 percent improvement in arthritis signs and symptoms (ACR 50) was seen in 47 of 70 patients receiving SIMPONI 50 mg and 70 of 130 patients receiving SIMPONI 100 mg, respectively, while 70 percent improvement (ACR 70) was seen in 31 of 70 patients and 48 of 130 patients in the SIMPONI 50 mg and 100 mg dose groups, respectively.

In a similar analysis, SIMPONI-treated patients also experienced sustained improvements in skin manifestations of PsA through two years. Patients with great
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

6

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
2. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
3. Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System
4. Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
5. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
6. Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis
7. Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients
8. Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Daulton, CEO of Mammotome, a division of Devicor Medical Products, ... Cincinnati chapter of the Association for Corporate ... executive who is also a breast cancer survivor, led the ... of 2010. Daulton will be presented with the award at ... on May 22. The ACG Deal Maker Awards ...
(Date:5/21/2013)... , May 21, 2013 /PRNewswire-iReach/ -- The 2013 ... NJ has attracted the greatest number of "Emerging" ... President, Mark Alexay .  "No ... to attend this year.  The show,s still 4 months ... companies.  This is a big surprise and great ...
(Date:5/21/2013)... CLARA, Calif. , May 21, 2013 ... game-changing embedded-ultrasound platform, today announced the introduction ... that allows complete network-based communications with all ... its latest embedded-ultrasound technology, including this new ... Sao Paulo, Brazil from ...
Breaking Medicine Technology:Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 3Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2
... May 11 The DNA Medicine Institute announced today that ... the Bill & Melinda Gates Foundation.  The grant will support an innovative ... titled "Optomagnetic Finger Scanner for Malaria." , ... Dr. Chan,s project is one of 78 grants announced by ...
... CHANGCHUN, China and LOS ... Inc. (OTC Bulletin Board: CYXN) (the "Company" or,"China Yongxin"), one ... today,announced that on March 31st, 2010 , the Company,s ... as one of the,qualified pharmaceuticals distributors for Jilin ...
Cached Medicine Technology:DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 2DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 3China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province 2China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province 3
(Date:5/21/2013)... 21, 2013 According to a May 13, ... Use of Botox,” Botox injections have become the ... in 2002 (Go to goo.gl/8iYbD). Although it is mostly associated ... men. The injection makes facial wrinkles less visible by paralyzing ... for about three months. This means that people who are ...
(Date:5/21/2013)... Global Proving Ground (GPG), a fast ... online retailer of health and fitness supplements, are partnering ... Warrior Island. “We cast the show by having ... with our unique social networking platform,” states show’s creator ... on an island in the Pacific Ocean, where they ...
(Date:5/21/2013)... (May 21, 2013) Research into genetic features of ... of Colorado School of Medicine may lead to improved ... paper published online by JAMA . , The ... survival in some cases of pulmonary fibrosis, a chronic ... As a result of the study, researchers may want ...
(Date:5/21/2013)... The Las Vegas personal injury law firm Benson, Bertoldo, ... a senior at Coronado High School, is the winner of ... As the winner of the essay contest, Crawford received a ... 1, 2012 and ran through April 30th, 2013. Participating senior ... essay on “The Role of the civil tort system.” The ...
(Date:5/21/2013)... While North Carolina is synonymous with golf, ... Brunswick Plantation & Golf Resort is synonymous with affordable ... 27 holes of "Top10" championship golf. , With ... the Top 10 from an industry expert ... task of selecting the course to play. Guests staying ...
Breaking Medicine News(10 mins):Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Benson, Bertoldo, Baker & Carter is Pleased to Announce the Winner of its First Annual College Scholarship Essay Contest 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2
... Injection System, designed specifically to allow fast, accurate and ... a valuable instrument in the fight against disease // ... ability to adjust pressure and volume to meet varied ... unique situation especially should there be a pandemic as ...
... a crucial role in deciding if an embryo should develop ... into a male), could explain the high incidence of Parkinson's ... of testes is also produced by Parkinson's affected areas in ... of California. ,The SRY gene was discovered in ...
... cardiologists are well informed about the possibility of reduction in ... vegetarian diet, they fail to recommend patients under an impression ... ,With this on one side, studies conducted on compliance ... are more than willing to adapt the low-fat diet, devoid ...
... of Health (NIH) said that Heart health risk can ... exercise, learning new// things and staying socially connected. This ... ,William Thies, PhD, vice president, Medical ... specific combinations of lifestyle choices, and also future therapies, ...
... might be able to reduce the harmful effects caused to ... reserachers at the Cornell// University. Foetal Alcohol Syndrome (FAS) results ... known cure for it. ,The reserachers say that ... ill effects of this particular syndrome. The researchers arrived at ...
... The Office for National Statistics in the UK has said that ... 42 percent in 2004 from 12 percent in 1980. The ONS ... the increase was only 33 percent. ,The survey ... from 2.9 to 2.4 people from 1971 to 2005. "Although most ...
Cached Medicine News:Health News:Needle-Free Injection System Ideal for Pandemic Outbreaks 2Health News:Needle-Free Injection System Ideal for Pandemic Outbreaks 3Health News:Sex Determination Gene Blamed For High Incidence Of Parkinson’s In Me 2Health News:Cognitive deterioration in the older generation can be prevented by modifying the lifestyle 2
Value-Line oxygen flowmeters. ,Options: , For security chain, add suffix S to model number. Example: FMQ107S. , For Canadian Color-Code, add suffix FMQ104C. , For Double Flowmeters with Power Take-Of...
... with brass and aluminum body., ... suffix S to model number. Example: ... suffix C to model number. Example: ... Power Take-Off, add PT to model ...
FM Style Neonatal Flowmeters (Brass Body)...
... designed specifically for detection of recent-onset neovascular ... perimeter maps and quantifies visual field defects ... AMD to the wet stage of the ... compensate for small visual field defects, the ...
Medicine Products: